A Post-Authorisation Safety Study to Evaluate the Safety of Marstacimab Among Patients with Haemophilia A or B using Real-World Data in Haemophilia Registers First published 10/06/2026 Last updated 10/06/2026 EU PAS number:EUPAS1000000947 Study Planned